Phase I/II study of bexarotene capsule (BSC-1) in patients with Cutaneous T-cell Lymphoma (CTCL).
Phase of Trial: Phase I/II
Latest Information Update: 01 Feb 2017
At a glance
- Drugs Bexarotene (Primary)
- Indications Cutaneous T cell lymphoma
- Focus Therapeutic Use
- Sponsors Minophagen
- 07 Apr 2016 Status changed from active, no longer recruiting to completed.
- 18 Jun 2014 Planned End Date changed from 1 Mar 2014 to 27 Dec 2013 as reported by University Hospital Medical Information Network - Japan.
- 18 Jun 2014 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.